ARGENT BIOPHARMA LIMITED - Announcements

Market Cap $14.03M Add to my watchlist

Healthcare

Argent BioPharma Ltd, formerly MGC Pharmaceuticals Ltd, is an Australia-based drug... Argent BioPharma Ltd, formerly MGC Pharmaceuticals Ltd, is an Australia-based drug discovery company. The Company is focused on developing and supplying accessible and ethically produced plant-derived medicines, combining in-house research with technologies. Its approach combines in-house research with technology, all discovering and producing treatments for unmet medical conditions. Its investigational medicinal (IMPs) products include CannEpil, CimetrA and CogniCann. CimetrA is a phyto medicine based on natural ingredients from Curcumin and Boswellia serrata, delivered in the nanoparticle delivery system, which is being developed for acute lung injury and acute respiratory distress syndrome (ARDS). CannEpil is a phyto medicine based on phytocannabinoid is being developed for the treatment of refractory epilepsy and cerebral palsy. CogniCann is a phyto medicine based on phytocannabinoids is in investigation stage as a treatment for the symptoms associated with dementia and Alzheimer.More

Announcements

Filter Results

All Price Sensitive Only

RGT	Notification of cessation of securities - MXC		09/09/21	21.78KB	Share
RGT	Application for quotation of securities - MXC		09/09/21	30.45KB	Share
RGT	CIMETRA IMPORT APPROVAL GRANTED FOR INDIA	PRICE SENSITIVE	03/09/21	261.97KB	Share
RGT	Preliminary Final Report	PRICE SENSITIVE	01/09/21	558.5KB	Share
RGT	Proposed issue of securities - MXC		30/08/21	25.3KB	Share
RGT	Information on expiring options		27/08/21	175.52KB	Share
RGT	MGC PHARMA EXECUTES US$24M US SUPPLY AGREEMENT	PRICE SENSITIVE	27/08/21	331.6KB	Share
RGT	Results of General Meeting		13/08/21	311.67KB	Share
RGT	General Meeting Web Cast Facility		06/08/21	193.66KB	Share
RGT	Notice to Holders of Expiring Options		03/08/21	1.4MB	Share
RGT	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	27/07/21	1.12MB	Share
RGT	Response to ASX Query Letter	PRICE SENSITIVE	20/07/21	695.84KB	Share
RGT	Amendment to Appendix 3H lodged 13 July 2021		16/07/21	419.52KB	Share
RGT	PATENT APPLICATION LODGED FOR NOVEL DRUG DELIVERY SYSTEM	PRICE SENSITIVE	15/07/21	268.36KB	Share
RGT	Notification of cessation of securities - MXC		13/07/21	21.72KB	Share
RGT	s708A(5)(e) Cleansing Notice - Issue of Shares		13/07/21	233.7KB	Share
RGT	Application for quotation of securities - MXC		13/07/21	27.87KB	Share
RGT	1ST PATIENT RECRUITED INTO CIMETRA PHASE 3 CLINICAL TRIAL	PRICE SENSITIVE	13/07/21	949.02KB	Share
RGT	Cleansing Notice on Issue of Shares		09/07/21	234.02KB	Share
RGT	Application for quotation of securities - MXC		09/07/21	24.82KB	Share
RGT	Notice of General Meeting/Proxy Form		09/07/21	2.05MB	Share
RGT	CANNEPIL AVAILABLE FOR FREE DISPENSING IN IRELAND	PRICE SENSITIVE	15/06/21	267.63KB	Share
RGT	Issue of shares and resignation of Company Secretary		15/06/21	235.11KB	Share
RGT	Application for quotation of securities - MXC		15/06/21	24.81KB	Share
RGT	Application for quotation of securities - MXC		15/06/21	24.91KB	Share
RGT	Proposed issue of securities - MXC		11/06/21	24.58KB	Share
RGT	Company Secretary Appointment		09/06/21	231.66KB	Share
RGT	MGC PHARMA 2021 CLINICAL TRIALS PROGRAM UPDATE	PRICE SENSITIVE	25/05/21	207.37KB	Share
RGT	CIMETRA PATENT SUBMITTED TO EUROPEAN IP OFFICE	PRICE SENSITIVE	18/05/21	220.44KB	Share
RGT	Appendix 3G x 3		14/05/21	754.44KB	Share
RGT	Appendix 2A		14/05/21	558.01KB	Share
RGT	FURTHER FINDINGS ON ARTEMIC AS ANTI-INFLAMMATORY AGENT	PRICE SENSITIVE	07/05/21	359.71KB	Share
RGT	Trading Halt	PRICE SENSITIVE	06/05/21	198.07KB	Share
RGT	Pause in Trading	PRICE SENSITIVE	06/05/21	117.07KB	Share
RGT	$1M ORDER FOR ARTEMIC RESCUE FROM SWISS PHARMACAN	PRICE SENSITIVE	04/05/21	200.73KB	Share
RGT	ARTEMIC SUBMITTED TO HEALTH CANADA	PRICE SENSITIVE	28/04/21	178.6KB	Share
RGT	MARCH QUARTERLY ACTIVITY AND CASHFLOW REPORT	PRICE SENSITIVE	27/04/21	937.1KB	Share
RGT	Proposed issue of Securities - MXC		22/04/21	31.22KB	Share
RGT	MGC PHARMA TO ACQUIRE MEDICAL RESEARCH COMPANY MEDICANL	PRICE SENSITIVE	22/04/21	232.71KB	Share
RGT	Appendix 2A - Option Conversion		16/04/21	555.41KB	Share
RGT	INVESTOR PRESENTATION	PRICE SENSITIVE	09/04/21	5.04MB	Share
RGT	Proposed issue of Securities - MXC		09/04/21	31.71KB	Share
RGT	Change of Company Secretary, Perf Rights & Remuneration		09/04/21	193.97KB	Share
RGT	MXC COMPLETES FIRST ARTEMIC ORDER, MARCH QTR RECORD REVENUE	PRICE SENSITIVE	07/04/21	344.84KB	Share
RGT	Results of General Meeting		01/04/21	342.29KB	Share
RGT	Appendix 2A		24/03/21	450.46KB	Share
RGT	Ethics Committee Approval Granted Phase III Clinical Trial	PRICE SENSITIVE	23/03/21	324.23KB	Share
RGT	MGC Pharma General Meeting Information and Webinar		19/03/21	168.98KB	Share
RGT	Appendix 2A		09/03/21	452.07KB	Share
RGT	Change of Director's Interest x3		09/03/21	217.9KB	Share
RGT	SwissPharmaCan AG increases initial purchase order	PRICE SENSITIVE	03/03/21	288.25KB	Share
RGT	Half Yearly Report and Accounts	PRICE SENSITIVE	26/02/21	1005.1KB	Share
RGT	Notice of Meeting and Incentive Share Plan		25/02/21	713.97KB	Share
RGT	Master Suppy and Distribution Agreement for ArtemiC Rescue		18/02/21	268.62KB	Share
RGT	LSE Dual Listing & Depositary Interest Information		16/02/21	226.31KB	Share
RGT	New In-vitro cannabinoid study on Glioblastoma treatment		15/02/21	275.47KB	Share
RGT	Corporate Governance Plan		11/02/21	678.04KB	Share
RGT	Appendix 2A		10/02/21	438.86KB	Share
RGT	MGC Pharma Welcomes Admission to the LSE		10/02/21	218.2KB	Share
RGT	Proposed issue of Securities - MXC		09/02/21	24.62KB	Share
RGT	Disclosure Document		09/02/21	329.11KB	Share
RGT	Proposed issue of Securities - MXC		04/02/21	25.47KB	Share
RGT	MGC Pharma first medicinal cannabis company to list on LSE	PRICE SENSITIVE	04/02/21	247.18KB	Share
RGT	Trading Halt	PRICE SENSITIVE	02/02/21	557.29KB	Share
RGT	MGC Pharma Investor Presentation	PRICE SENSITIVE	02/02/21	1.78MB	Share
RGT	MGC Pharma to list on the London Stock Exchange	PRICE SENSITIVE	02/02/21	230.21KB	Share
RGT	December Quarterly Activity and Cashflow Report	PRICE SENSITIVE	22/01/21	407.36KB	Share
RGT	Key Appointment - Global Chief Sales Officer		13/01/21	216.66KB	Share
RGT	Appendix 2A		22/12/20	443.83KB	Share
RGT	MGC Pharma to receive grant for Malta production facility		22/12/20	220.78KB	Share
RGT	ArtemiC Phase II Clinical Trial Results	PRICE SENSITIVE	15/12/20	306.42KB	Share
RGT	Appendix 2A		11/12/20	443.29KB	Share
RGT	Completion of Unmarketable Parcel Share Sale Facility		09/12/20	197.19KB	Share
RGT	ArtemiC Phase II Clinical Trial Results Update		07/12/20	213.83KB	Share
RGT	MGC Pharma to benefit from UN vote to reschedule Cannabis		03/12/20	211.97KB	Share
RGT	Amended MGC Nutraceuticals Sales Update		02/12/20	217.38KB	Share
RGT	MGC Nutraceuticals Sale Update		02/12/20	216.34KB	Share
RGT	Company Secretary Appointment		30/11/20	149.84KB	Share
RGT	Issue of Securities - Appendix 2A		24/11/20	296.05KB	Share
RGT	Prospectus	PRICE SENSITIVE	23/11/20	456.17KB	Share
RGT	Proposed issue of Securities - MXC		23/11/20	34.58KB	Share
RGT	Drawdown of $3.5m Convertible Note		23/11/20	126.22KB	Share
RGT	MGC PHARMA COMPLETES ACQUISITION OF TELEHEALTH PLATFORM MCC	PRICE SENSITIVE	23/11/20	178.95KB	Share
RGT	FURTHER SUCCESSFUL RESULTS FROM GLIOBLASTOMA RESEARCH	PRICE SENSITIVE	17/11/20	525.24KB	Share
RGT	Conversion of Convertible Notes - Appendix 2A		13/11/20	312.4KB	Share
RGT	COMPLETION OF PHASE II CLINICAL TRIAL ON COVID-19 PATIENTS	PRICE SENSITIVE	05/11/20	191.94KB	Share
RGT	Constitution		04/11/20	616.72KB	Share
RGT	Results of Annual General Meeting		04/11/20	360.42KB	Share
RGT	AGM Presentation		04/11/20	1.23MB	Share
RGT	Annual Report 2020		28/10/20	7.73MB	Share
RGT	MGC Pharma AGM Information and Webinar		28/10/20	131.96KB	Share
RGT	September Quarterly Activity and Cashflow Report	PRICE SENSITIVE	27/10/20	379.54KB	Share
RGT	Unmarketable Parcel Share Sale Update		26/10/20	130.75KB	Share
RGT	MGC PHARMA DELIVERS RECORD CONSECUTIVE WEEKLY SALES GROWTH	PRICE SENSITIVE	20/10/20	265.48KB	Share
RGT	ARTEMIC HISTOLOGY ON RATS CONFIRM NO PATHOLOGICAL IMPACT	PRICE SENSITIVE	14/10/20	244.52KB	Share
RGT	FIRST HIGH THC PRODUCTS SHIPPED DIRECT TO BRAZIL PATIENTS	PRICE SENSITIVE	12/10/20	186.98KB	Share
RGT	MGC PHARMA LAUNCHES CANNEPIL APP	PRICE SENSITIVE	07/10/20	218KB	Share
RGT	Letter to Shareholders - Upcoming Annual General Meeting		02/10/20	303.93KB	Share
RGT	Notice of Annual General Meeting/Proxy Form		02/10/20	645.79KB	Share
RGT	Appendix 4G and Corporate Governance Statement		01/10/20	357.64KB	Share

RGT Notification of cessation of securities - MXC
09/09/21		21.78KB	Share
RGT Application for quotation of securities - MXC
09/09/21		30.45KB	Share
RGT CIMETRA IMPORT APPROVAL GRANTED FOR INDIA
03/09/21	PRICE SENSITIVE	261.97KB	Share
RGT Preliminary Final Report
01/09/21	PRICE SENSITIVE	558.5KB	Share
RGT Proposed issue of securities - MXC
30/08/21		25.3KB	Share
RGT Information on expiring options
27/08/21		175.52KB	Share
RGT MGC PHARMA EXECUTES US$24M US SUPPLY AGREEMENT
27/08/21	PRICE SENSITIVE	331.6KB	Share
RGT Results of General Meeting
13/08/21		311.67KB	Share
RGT General Meeting Web Cast Facility
06/08/21		193.66KB	Share
RGT Notice to Holders of Expiring Options
03/08/21		1.4MB	Share
RGT Quarterly Activities/Appendix 4C Cash Flow Report
27/07/21	PRICE SENSITIVE	1.12MB	Share
RGT Response to ASX Query Letter
20/07/21	PRICE SENSITIVE	695.84KB	Share
RGT Amendment to Appendix 3H lodged 13 July 2021
16/07/21		419.52KB	Share
RGT PATENT APPLICATION LODGED FOR NOVEL DRUG DELIVERY SYSTEM
15/07/21	PRICE SENSITIVE	268.36KB	Share
RGT Notification of cessation of securities - MXC
13/07/21		21.72KB	Share
RGT s708A(5)(e) Cleansing Notice - Issue of Shares
13/07/21		233.7KB	Share
RGT Application for quotation of securities - MXC
13/07/21		27.87KB	Share
RGT 1ST PATIENT RECRUITED INTO CIMETRA PHASE 3 CLINICAL TRIAL
13/07/21	PRICE SENSITIVE	949.02KB	Share
RGT Cleansing Notice on Issue of Shares
09/07/21		234.02KB	Share
RGT Application for quotation of securities - MXC
09/07/21		24.82KB	Share
RGT Notice of General Meeting/Proxy Form
09/07/21		2.05MB	Share
RGT CANNEPIL AVAILABLE FOR FREE DISPENSING IN IRELAND
15/06/21	PRICE SENSITIVE	267.63KB	Share
RGT Issue of shares and resignation of Company Secretary
15/06/21		235.11KB	Share
RGT Application for quotation of securities - MXC
15/06/21		24.81KB	Share
RGT Application for quotation of securities - MXC
15/06/21		24.91KB	Share
RGT Proposed issue of securities - MXC
11/06/21		24.58KB	Share
RGT Company Secretary Appointment
09/06/21		231.66KB	Share
RGT MGC PHARMA 2021 CLINICAL TRIALS PROGRAM UPDATE
25/05/21	PRICE SENSITIVE	207.37KB	Share
RGT CIMETRA PATENT SUBMITTED TO EUROPEAN IP OFFICE
18/05/21	PRICE SENSITIVE	220.44KB	Share
RGT Appendix 3G x 3
14/05/21		754.44KB	Share
RGT Appendix 2A
14/05/21		558.01KB	Share
RGT FURTHER FINDINGS ON ARTEMIC AS ANTI-INFLAMMATORY AGENT
07/05/21	PRICE SENSITIVE	359.71KB	Share
RGT Trading Halt
06/05/21	PRICE SENSITIVE	198.07KB	Share
RGT Pause in Trading
06/05/21	PRICE SENSITIVE	117.07KB	Share
RGT $1M ORDER FOR ARTEMIC RESCUE FROM SWISS PHARMACAN
04/05/21	PRICE SENSITIVE	200.73KB	Share
RGT ARTEMIC SUBMITTED TO HEALTH CANADA
28/04/21	PRICE SENSITIVE	178.6KB	Share
RGT MARCH QUARTERLY ACTIVITY AND CASHFLOW REPORT
27/04/21	PRICE SENSITIVE	937.1KB	Share
RGT Proposed issue of Securities - MXC
22/04/21		31.22KB	Share
RGT MGC PHARMA TO ACQUIRE MEDICAL RESEARCH COMPANY MEDICANL
22/04/21	PRICE SENSITIVE	232.71KB	Share
RGT Appendix 2A - Option Conversion
16/04/21		555.41KB	Share
RGT INVESTOR PRESENTATION
09/04/21	PRICE SENSITIVE	5.04MB	Share
RGT Proposed issue of Securities - MXC
09/04/21		31.71KB	Share
RGT Change of Company Secretary, Perf Rights & Remuneration
09/04/21		193.97KB	Share
RGT MXC COMPLETES FIRST ARTEMIC ORDER, MARCH QTR RECORD REVENUE
07/04/21	PRICE SENSITIVE	344.84KB	Share
RGT Results of General Meeting
01/04/21		342.29KB	Share
RGT Appendix 2A
24/03/21		450.46KB	Share
RGT Ethics Committee Approval Granted Phase III Clinical Trial
23/03/21	PRICE SENSITIVE	324.23KB	Share
RGT MGC Pharma General Meeting Information and Webinar
19/03/21		168.98KB	Share
RGT Appendix 2A
09/03/21		452.07KB	Share
RGT Change of Director's Interest x3
09/03/21		217.9KB	Share
RGT SwissPharmaCan AG increases initial purchase order
03/03/21	PRICE SENSITIVE	288.25KB	Share
RGT Half Yearly Report and Accounts
26/02/21	PRICE SENSITIVE	1005.1KB	Share
RGT Notice of Meeting and Incentive Share Plan
25/02/21		713.97KB	Share
RGT Master Suppy and Distribution Agreement for ArtemiC Rescue
18/02/21		268.62KB	Share
RGT LSE Dual Listing & Depositary Interest Information
16/02/21		226.31KB	Share
RGT New In-vitro cannabinoid study on Glioblastoma treatment
15/02/21		275.47KB	Share
RGT Corporate Governance Plan
11/02/21		678.04KB	Share
RGT Appendix 2A
10/02/21		438.86KB	Share
RGT MGC Pharma Welcomes Admission to the LSE
10/02/21		218.2KB	Share
RGT Proposed issue of Securities - MXC
09/02/21		24.62KB	Share
RGT Disclosure Document
09/02/21		329.11KB	Share
RGT Proposed issue of Securities - MXC
04/02/21		25.47KB	Share
RGT MGC Pharma first medicinal cannabis company to list on LSE
04/02/21	PRICE SENSITIVE	247.18KB	Share
RGT Trading Halt
02/02/21	PRICE SENSITIVE	557.29KB	Share
RGT MGC Pharma Investor Presentation
02/02/21	PRICE SENSITIVE	1.78MB	Share
RGT MGC Pharma to list on the London Stock Exchange
02/02/21	PRICE SENSITIVE	230.21KB	Share
RGT December Quarterly Activity and Cashflow Report
22/01/21	PRICE SENSITIVE	407.36KB	Share
RGT Key Appointment - Global Chief Sales Officer
13/01/21		216.66KB	Share
RGT Appendix 2A
22/12/20		443.83KB	Share
RGT MGC Pharma to receive grant for Malta production facility
22/12/20		220.78KB	Share
RGT ArtemiC Phase II Clinical Trial Results
15/12/20	PRICE SENSITIVE	306.42KB	Share
RGT Appendix 2A
11/12/20		443.29KB	Share
RGT Completion of Unmarketable Parcel Share Sale Facility
09/12/20		197.19KB	Share
RGT ArtemiC Phase II Clinical Trial Results Update
07/12/20		213.83KB	Share
RGT MGC Pharma to benefit from UN vote to reschedule Cannabis
03/12/20		211.97KB	Share
RGT Amended MGC Nutraceuticals Sales Update
02/12/20		217.38KB	Share
RGT MGC Nutraceuticals Sale Update
02/12/20		216.34KB	Share
RGT Company Secretary Appointment
30/11/20		149.84KB	Share
RGT Issue of Securities - Appendix 2A
24/11/20		296.05KB	Share
RGT Prospectus
23/11/20	PRICE SENSITIVE	456.17KB	Share
RGT Proposed issue of Securities - MXC
23/11/20		34.58KB	Share
RGT Drawdown of $3.5m Convertible Note
23/11/20		126.22KB	Share
RGT MGC PHARMA COMPLETES ACQUISITION OF TELEHEALTH PLATFORM MCC
23/11/20	PRICE SENSITIVE	178.95KB	Share
RGT FURTHER SUCCESSFUL RESULTS FROM GLIOBLASTOMA RESEARCH
17/11/20	PRICE SENSITIVE	525.24KB	Share
RGT Conversion of Convertible Notes - Appendix 2A
13/11/20		312.4KB	Share
RGT COMPLETION OF PHASE II CLINICAL TRIAL ON COVID-19 PATIENTS
05/11/20	PRICE SENSITIVE	191.94KB	Share
RGT Constitution
04/11/20		616.72KB	Share
RGT Results of Annual General Meeting
04/11/20		360.42KB	Share
RGT AGM Presentation
04/11/20		1.23MB	Share
RGT Annual Report 2020
28/10/20		7.73MB	Share
RGT MGC Pharma AGM Information and Webinar
28/10/20		131.96KB	Share
RGT September Quarterly Activity and Cashflow Report
27/10/20	PRICE SENSITIVE	379.54KB	Share
RGT Unmarketable Parcel Share Sale Update
26/10/20		130.75KB	Share
RGT MGC PHARMA DELIVERS RECORD CONSECUTIVE WEEKLY SALES GROWTH
20/10/20	PRICE SENSITIVE	265.48KB	Share
RGT ARTEMIC HISTOLOGY ON RATS CONFIRM NO PATHOLOGICAL IMPACT
14/10/20	PRICE SENSITIVE	244.52KB	Share
RGT FIRST HIGH THC PRODUCTS SHIPPED DIRECT TO BRAZIL PATIENTS
12/10/20	PRICE SENSITIVE	186.98KB	Share
RGT MGC PHARMA LAUNCHES CANNEPIL APP
07/10/20	PRICE SENSITIVE	218KB	Share
RGT Letter to Shareholders - Upcoming Annual General Meeting
02/10/20		303.93KB	Share
RGT Notice of Annual General Meeting/Proxy Form
02/10/20		645.79KB	Share
RGT Appendix 4G and Corporate Governance Statement
01/10/20		357.64KB	Share

REFRESH

First 2 3 4 5 6

(20min delay)
Last 31.0¢		Change 0.010(3.33%)		Mkt cap ! $14.03M

Open	High	Low	Value	Volume
31.0¢	31.0¢	31.0¢	$921	2.972K

Buyers (Bids)

No.	Vol.	Price($)
2	7046	31.0¢

Sellers (Offers)

Price($)	Vol.	No.
32.0¢	2380	2

View Market Depth

No.	Vol.	Price($)
2	7046	0.310
2	51648	0.300
1	17426	0.275
1	40820	0.245
1	18524	0.240

Price($)	Vol.	No.
0.320	2380	2
0.325	5304	1
0.330	2484	2
0.350	10135	2
0.370	1056	1

Last trade - 15.24pm 18/06/2024 (20 minute delay)

RGT (ASX) Chart

ARGENT BIOPHARMA LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories